Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical Experience of a Primary Accessory Breast Cancer Patient].
Ikarashi M, Nagahashi M, Endo M, Otani A, Tsuchida J, Moro K, Niwano T, Yamaura K, Toshikawa C, Hasegawa M, Nakajima M, Sakata J, Kobayashi T, Kameyama H, Wakai T. Ikarashi M, et al. Gan To Kagaku Ryoho. 2017 Nov;44(12):1104-1106. Gan To Kagaku Ryoho. 2017. PMID: 29394548 Japanese.
Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy.
Moro K, Nagahashi M, Uchida H, Oji M, Tsuchida J, Yamaura K, Toshikawa C, Nakano M, Ikarashi M, Muneoka Y, Tajima Y, Ichikawa H, Shimada Y, Sakata J, Koyama Y, Takabe K, Wakai T. Moro K, et al. Among authors: ikarashi m. World J Oncol. 2022 Dec;13(6):379-386. doi: 10.14740/wjon1530. Epub 2022 Dec 24. World J Oncol. 2022. PMID: 36660211 Free PMC article.
Oral Administration of Glucosylceramide Suppresses Tumor Growth by Affecting the Ceramide/Sphingosine-1-Phosphate Balance in Breast Cancer Tissue.
Moro K, Ichikawa H, Koyama Y, Abe S, Uchida H, Naruse K, Obata Y, Tsuchida J, Toshikawa C, Ikarashi M, Muneoka Y, Miura K, Tajima Y, Shimada Y, Kobayashi T, Sakata J, Takabe K, Wakai T. Moro K, et al. Among authors: ikarashi m. World J Oncol. 2023 Oct;14(5):430-437. doi: 10.14740/wjon1656. Epub 2023 Sep 20. World J Oncol. 2023. PMID: 37869237 Free PMC article.
[A Case of Breast Cancer with Metastatic Nodules in Additionally Resected Specimens].
Endo M, Nagahashi M, Tsuchida J, Moro K, Niwano T, Yamaura K, Toshikawa C, Hasegawa M, Ikarashi M, Nakajima M, Koyama Y, Kobayashi T, Sakata J, Kameyama H, Wakai T. Endo M, et al. Among authors: ikarashi m. Gan To Kagaku Ryoho. 2018 Dec;45(13):1860-1862. Gan To Kagaku Ryoho. 2018. PMID: 30692378 Japanese.
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
Tomioka N, Azuma M, Ikarashi M, Yamamoto M, Sato M, Watanabe KI, Yamashiro K, Takahashi M. Tomioka N, et al. Among authors: ikarashi m. Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9. Breast Cancer. 2018. PMID: 28488168
Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer.
Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J, Hasegawa M, Niwano T, Manba N, Ikarashi M, Kameyama H, Kobayashi T, Kosugi S, Wakai T. Toshikawa C, et al. Among authors: ikarashi m. J Clin Med Res. 2015 Aug;7(8):620-6. doi: 10.14740/jocmr2195w. Epub 2015 Jun 9. J Clin Med Res. 2015. PMID: 26124908 Free PMC article.
52 results